AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Lauer, SJ Shuster, JJ Mahoney, DH Winick, N Toledano, S Munoz, L Kiefer, G Pullen, JD Steuber, CP Camitta, BM
Citation: Sj. Lauer et al., A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acutelymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial, LEUKEMIA, 15(7), 2001, pp. 1038-1045

Authors: Dahlquist, LM Pendley, JS Power, TG Landthrip, DS Jones, CL Steuber, CP
Citation: Lm. Dahlquist et al., Adult command structure and children's distress during the anticipatory phase of invasive cancer procedures, CHILD HEA C, 30(2), 2001, pp. 151-167

Authors: Ravindranath, Y Chang, M Raimondi, S Carroll, AJ Steuber, CP Camitta, B Weinstein, H
Citation: Y. Ravindranath et al., Prognostic factors and patterns of failure in childhood acute myeloid leukemia: Experience on Pediatric Oncology Group Study # 8821, HEMAT BLOOD, 40, 2001, pp. 493-498

Authors: Chang, M Raimondi, SC Ravindranath, Y Carroll, AJ Camitta, B Gresik, MV Steuber, CP Weinstein, H
Citation: M. Chang et al., Prognostic factors in children and adolescents with acute myeloid leukemia(excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POC) Study 8821, LEUKEMIA, 14(7), 2000, pp. 1201-1207

Authors: Mahoney, DH Shuster, JJ Nitschke, R Lauer, S Steuber, CP Camitta, B
Citation: Dh. Mahoney et al., Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A pediatric oncology group study, J CL ONCOL, 18(6), 2000, pp. 1285-1294

Authors: Raimondi, SC Chang, MN Ravindranath, Y Behm, FG Gresik, MV Steuber, CP Weinstein, HJ Carroll, AJ
Citation: Sc. Raimondi et al., Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group Study - POG 8821, BLOOD, 94(11), 1999, pp. 3707-3716
Risultati: 1-6 |